PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
23-Apr-2024 CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy Janssen-Cilag International NV,
23-Apr-2024 MPE launches the Myeloma and AL Amyloidosis European Clinical Trial Navigator Myeloma Patients Europe (MPE)
23-Apr-2024 CellProthera to share results from its Phase I/IIb study investigating the safety and efficacy of ProtheraCytes (CD34+ expanded stem cells) in acute myocardial infarction CellProthera
21-Apr-2024 Agenda Announced for Semantic Data 2024: Taxonomy, Ontology, and Knowledge Graphs conference in London Henry Stewart Events
18-Apr-2024 Tereos unveils new Innovation Centre for European customers Tereos
18-Apr-2024 Servier Executive Committee appointments Servier
18-Apr-2024 Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium Xeltis
18-Apr-2024 Lucida Medical Ltd Blackford and Lucida Medical Partner
18-Apr-2024 ISPE Announces 2024 Facility of the Year Awards (FOYA) Category Winners ISPE
18-Apr-2024 Scientists uncover promising new treatment strategy for aggressive form of leukaemia The Institute of Cancer Research, London
18-Apr-2024 Beckman Coulter Life Sciences Launches QbD1200+ Total Organic Carbon Analyzer Beckman Coulter Life Sciences
18-Apr-2024 Healthcare providers must involve engineers in pursuit of Net Zero ambitions or risk missing targets – IMechE report The Institution of Mechanical Engineers
18-Apr-2024 Shape-shifting cancer cell discovery reveals two potential drug targets against skin cancer The Institute of Cancer Research
16-Apr-2024 PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis PureTech Health plc
16-Apr-2024 Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metereddose inhaler (pMDI) as a commitment to reducing the product’s carbon footprint Mundipharma and Vectura
16-Apr-2024 ELRIG UK and SRG Announce Partnership to Advance Life Science Professionals in Drug Discovery ELRIG UK
16-Apr-2024 Serum Institute of India and University of Oxford Strike Landmark Licensing Agreement for Meningitis-B Vaccine Serum Institute of India and University of Oxford
16-Apr-2024 Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568 Nxera Pharma
16-Apr-2024 GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA GILEAD
16-Apr-2024 ELRIG UK and SRG Announce Partnership to Advance Life Science Professionals in Drug Discovery ELRIG UK and SRG